Ashton T - Search Results

1

Likelihood of residential aged care use in later life: a simple approach to estimation with international comparison.

Broad JB, Ashton T, Gott M, McLeod H, Davis PB, Connolly MJ. Broad JB, et al. Among authors: ashton t. Aust N Z J Public Health. 2015 Aug;39(4):374-9. doi: 10.1111/1753-6405.12374. Epub 2015 Jun 11. Aust N Z J Public Health. 2015. PMID: 26095070 Free article.

2

Reports of the proportion of older people living in long-term care: a cautionary tale from New Zealand.

Broad JB, Ashton T, Lumley T, Connolly MJ. Broad JB, et al. Among authors: ashton t. Aust N Z J Public Health. 2013 Jun;37(3):264-71. doi: 10.1111/1753-6405.12069. Aust N Z J Public Health. 2013. PMID: 23731110 Free article.

3

Biases in describing residents in long-term residential aged care.

Broad JB, Ashton T, Lumley T, Boyd M, Kerse N, Connolly MJ. Broad JB, et al. Among authors: ashton t. N Z Med J. 2014 Sep 12;127(1402):50-61. N Z Med J. 2014. PMID: 25228421

4

The impact on health outcomes and healthcare utilisation of switching to generic medicines consequent to reference pricing: the case of lamotrigine in New Zealand.

Lessing C, Ashton T, Davis P. Lessing C, et al. Among authors: ashton t. Appl Health Econ Health Policy. 2014 Oct;12(5):537-46. doi: 10.1007/s40258-014-0110-0. Appl Health Econ Health Policy. 2014. PMID: 25005492

5

Selecting long-term care facilities with high use of acute hospitalisations: issues and options.

Broad JB, Ashton T, Lumley T, Boyd M, Kerse N, Connolly MJ. Broad JB, et al. Among authors: ashton t. BMC Med Res Methodol. 2014 Jul 22;14:93. doi: 10.1186/1471-2288-14-93. BMC Med Res Methodol. 2014. PMID: 25052433 Free PMC article.

6

The impact on health outcome measures of switching to generic medicines consequent to reference pricing: the case of olanzapine in New Zealand.

Lessing C, Ashton T, Davis PB. Lessing C, et al. Among authors: ashton t. J Prim Health Care. 2015 Jun 1;7(2):94-101. J Prim Health Care. 2015. PMID: 26125054

7

New Zealand patients' understanding of brand substitution and opinions on copayment options for choice of medicine brand.

Lessing C, Ashton T, Davis P. Lessing C, et al. Among authors: ashton t. Aust Health Rev. 2016 Jun;40(3):345-350. doi: 10.1071/AH15004. Aust Health Rev. 2016. PMID: 26363980

8

Transitions to and from long-term care facilities and length of completed stay: Reuse of population-based survey data.

Broad JB, Lumley T, Ashton T, Davis PB, Boyd M, Connolly MJ. Broad JB, et al. Among authors: ashton t. Australas J Ageing. 2017 Jun;36(2):E1-E7. doi: 10.1111/ajag.12378. Epub 2017 Mar 20. Australas J Ageing. 2017. PMID: 28319325

9

Do users of risperidone who switch brands because of generic reference pricing fare better or worse than non-switchers? A New Zealand natural experiment.

Lessing C, Ashton T, Davis P. Lessing C, et al. Among authors: ashton t. Adm Policy Ment Health. 2015 Nov;42(6):695-703. doi: 10.1007/s10488-014-0606-9. Adm Policy Ment Health. 2015. PMID: 25331449

10

An Evaluation of Health Service Impacts Consequent to Switching from Brand to Generic Venlafaxine in New Zealand under Conditions of Price Neutrality.

Lessing C, Ashton T, Davis P. Lessing C, et al. Among authors: ashton t. Value Health. 2015 Jul;18(5):646-54. doi: 10.1016/j.jval.2015.02.020. Epub 2015 Jul 22. Value Health. 2015. PMID: 26297093 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters